Question 1

How many shares of ARWR does UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC own?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 964,479 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN).

Question 2

What is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's ARWR position worth?

Accepted Answer

As of 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's ARWR position is worth $78.6M.

Question 3

Is UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC buying or selling ARWR?

Accepted Answer

In 2026-Q2, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC decreased their ARWR position (-27.5% change in shares).

Question 4

When did UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first buy ARWR?

Accepted Answer

Based on available 13F filings, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC first reported a position in ARWR in 2024-Q3. They have held the position across 31 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	964,479	-27.5%	$78.6M	0.0%	$81.51	0
2026-Q1	Increased	1.3M	+5.6%	$83.5M	0.0%	$64.10	31
2025-Q4	Decreased	1.3M	-28.4%	$83.7M	0.0%	$67.25	0
2025-Q3	Decreased	1.8M	-34.5%	$60.7M	0.0%	$33.78	0
2025-Q2	Decreased	2.7M	-43.9%	$42.4M	0.0%	$16.08	0
2025-Q1	Increased	4.8M	+138.1%	$61M	0.0%	$13.82	48
2024-Q4	Decreased	2M	-6.7%	$37.8M	0.0%	$18.61	0
2024-Q3	Decreased	2.2M	-5.9%	$41.7M	0.0%	$19.67	0